.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Posters on the topic "Infections at Interfaces"

Back

P-1-1

Differential rates of Mycobacterium tuberculosis transmission associate with host-pathogen sympatry

Dr. Dr. Matthias Groeschel (Berlin / DE)

P-1-10

Low humoral immunity against highly pathogenic avian influenza H5N1 Clade 2.3.4.4b

Katharina Daniel (Cologne / DE)

P-1-11

Fever vs history of fever: Pyrogenic and cryogenic responses in children with acute febrile illnesses in Lambaréné, Gabon

Therese Vanessa Amana Bokagne (Lambaréné / GA; Tübingen / DE)

P-1-12

German clinical practice guideline for the management of Outpatient Parenteral Antimicrobial Therapy (OPAT)

Dr. med. Miriam Songa Stegemann (Berlin / DE)

P-1-13

Remote study participants recruitment, management and sampling: a swift combination of the PIA app and the dried blood spot (DBS) method

PD Dr. Noemi Castelletti (Munich / DE; Germany / DE; Neuherberg / DE)

P-1-14

Outer membrane vesicles of Klebsiella pneumoniae decrease bactericidal properties of alveolar macrophages

Dr. Mohammad Estiri (Gießen / DE)

P-1-15

Prevalence and associated factors of gametocyte carriage distribution in rural and urban areas

Dr. Hounmenou Zinsou Alex (Lambaréné / GA)

P-1-16

M. tuberculosis reroutes NETosis away from PAD4 towards Gasdermin D and its prevention results in bacterial control

Dr. Tobias Dallenga (Borstel / DE)

P-1-17

Studies on the presence of neutrophil extracellular traps (NETs) in different types of urinary tract infections

Lena Schröder Alvarez (Gießen / DE)

P-1-18

Testing of darobactin derivatives in pneumonia caused by Klebsiella pneumoniae and Pseudomonas aeruginosa

Julia Findeisen (Gießen / DE)

P-1-19

Galleria mellonella larvae as a model for studying implant-associated biofilm infections

Kamran Ahmad Mirza (Jena / DE)

P-1-2

Trends in the availability and prices of quality-assured tuberculosis drugs: a systematic analysis of Global Drug Facility Product Catalogs from 2001 to 2024

Dr. Stefan Kohler (Heidelberg / DE; Berlin / DE)
Dr. Nicolas Paul (Heidelberg / DE)

P-1-20

The influence of comorbidity, age, sex, and comorbidities on COVID-19 mortality throughout the course of the SARS-CoV-2 pandemic in Europe: Data from the LEOSS study

Dr. Laura Wagner (Munich / DE)

P-1-21

Vaginal microbial dynamics are linked to functional shifts with implications on colonization resistance to STIs

Dr. Simon Graspeuntner (Lübeck / DE)

P-1-22

Inhibition of homotypic fusion during co-incubation of Chlamydia muridarum and Enterococcus faecalis as a possible modulator of colonization resistance to chlamydial infection

Fleur Deitmar (Lübeck / DE)

P-1-23

Easy to use application to monitor community-acquired infections (CAI-App)

Dr. Nadja Käding (Lübeck / DE)

P-1-24

Advanced in vitro biofilm models for real-time analysis of Pseudomonas aeruginosa and Staphylococcus aureus responses to antimicrobials

Tinatini Tchatchiashvili (Jena / DE)

P-1-25

Prevalence study of the microbiome and development of antibiotic resistance in children with Crohn's disease

Karin Fetter (Gießen / DE)

P-1-26

Inhibitory effects of Ruminococcus bromii on Clostridioides difficile infections

Reza Naderei Ramezan Abad (Hannover / DE)

P-1-28

Characterisation of aerosolised SARS-CoV-2 spectral sensitivity to light from 185 to 528 nm

Felix Esslinger (Munich / DE)

P-1-29

Helicobacter pylori infection confers increased colorectal cancer risk depending on CagA by disrupting intestinal homeostasis

Veronika Engelsberger (Munich / DE)

P-1-3

Body mass index trajectories and association with tuberculosis risk in a cohort of household contacts in southern Africa

Ms. Leyla Larsson (Munich / DE)

P-1-30

Quantification of bacterial sialidases and members of the nan gene cluster in combination with CTACK in bile for the early detection of cholangiocellular carcinoma in patients with primary sclerosing cholangitis (PSC)

Prof. Benjamin Heidrich (Hannover / DE)

P-1-31

An anti-virulence strategy to treat Salmonella infections: Development of lead compounds targeting the transcriptional regulator HilD

Abdelhakim Boudrioua (Tübingen / DE)

P-1-32

Assessing the impact of anemia on infant cognitive development at Agogo, Asante Akyem North, Ghana

Felix Osei Boateng (Kumasi / GH)

P-1-33

Addressing host susceptibility in mycobacterium tuberculosis infection: A comparative analysis of lipid droplet accumulation in murine C3HeB/FeJ and C57BL/6 macrophages

Linda Zemke (Borstel / DE)

P-1-34

Giardia lamblia infection and its co-existence with malaria susceptibility in young children at Agogo, Asante Akyem North, Ghana: Implications for child health and nutrition

Henry Hanson (Kumasi / GH)

P-1-35

Microbial profiling of urosepsis patients

Parisa Golbargtaklimi (Gießen / DE)

P-1-36

Expression of the broad spectrum antiviral Griffithsin in human cells: looking for a selective window

Adrian Stach (Munich / DE)

P-1-37

Making health information accessible: The COVID-19 patient guideline

Dr. med. Miriam Songa Stegemann (Berlin / DE)

P-1-39

The TTU-TB analytical platform

Dr. Dominik Schwudke (Borstel / DE)

P-1-4

Characterising the spectrum of tuberculosis by generation of reference standards and application of multi-state modelling: a proof of concept study

Ms. Leyla Larsson (Munich / DE)

P-1-40

Comprehensive analysis of Tuberculostearic acid-containing lipids during host-pathogen interactions in Mycobacterium tuberculosis infection

Dr. Nadine Aboutara (Sülfeld / DE)

P-1-5

Infectious diseases tissue biobanking and biodata management of the German Center for Infection Research – a key infrastructure for multiple research approaches

Dr. Tilman Pfeffer (Heidelberg / DE)

P-1-6

Digital services for DZIF researchers: Data & Tools-Hub, Metadata Repository and Central Biosample Register

Demski Hans (Neuherberg / DE)

P-1-7

Oscillatory characteristics in infectious diseases

Dr. rer. medic. Fabian Standl (Munich / DE; Essen / DE)

P-1-8

A human cerebral organoid model to investigate the host-pathogen determinants of Ebola virus persistence in the central nervous system

Lina Widerspick (Hamburg / DE)

P-1-9

Identification of a novel effector in HBV replication: PAXX

Ecem Sekban (Munich / DE)

- Imprint
- Privacy

Cookie settings

We use cookies on our website. Cookies are small (text) files that are created and stored on your device (e.g., smartphone, notebook, tablet, PC). Some of these cookies are technically necessary to operate the website, other cookies are used to extend the functionality of the website or for marketing purposes. Apart from the technically necessary cookies, you are free to allow or not allow cookies when visiting our website.

NecessaryStatistics

Imprint | Privacy